Source: WASHINGTON UNIV submitted to NRP
FACTORS AFFECTING TRANSMISSION OF PRIONS BETWEEN SPECIES
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
0202406
Grant No.
2005-35201-15383
Cumulative Award Amt.
(N/A)
Proposal No.
2004-04254
Multistate No.
(N/A)
Project Start Date
Sep 1, 2005
Project End Date
Aug 31, 2007
Grant Year
2005
Program Code
[32.0]- (N/A)
Recipient Organization
WASHINGTON UNIV
#1 NORTH BROOKINGS DRIVE, CAMPUS BOX 1137
ST LOUIS,MO 63130
Performing Department
SCHOOL OF MEDICINE
Non Technical Summary
Prion diseases are neurodegenerative protein aggregation disorders that have inherited, sporadic, and infectious origins. Normally, prions from one species are not infectious to another species, so a species barrier against transmission exists. However, there is evidence that the species barrier can be overcome. For example, the prion strain responsible for Bovine Spongiform Encephalopathy ("Mad Cow Disease") in cattle may have infected humans, resulting in new variant Creutzfeldt-Jakob Disease (vCJD). Very little is understood about how the species barrier is maintained or how it is overcome. The goal of this project is to determine environmental conditions and genetic factors that contribute to overcoming the prion species barrier. Understanding the underlying principles of the prion species barrier and how it is overcome may be keys to preventing transmission and to identifying new therapeutic targets.
Animal Health Component
20%
Research Effort Categories
Basic
80%
Applied
20%
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
7123310100010%
7123320100010%
7123410100010%
7123440100010%
7123610100010%
7123620100010%
7123899100010%
7124020100020%
7124099100010%
Goals / Objectives
Determine environmental conditions and genetic factors that contribute to the ability to overcome the prion species barrier. Elucidate the structural requirements for the heterotypic protein aggregation that may occur during interspecies prion transmission.
Project Methods
The species barrier observed with yeast prions mimics that of the mammalian prion protein. A cytosolic protein-protein interaction system in yeast will be used to investigate environmental factors and cellular proteins that influence prion propagation and transmission. Chemical and genetic screens will be conducted to assess environmental conditions and genetic factors that eliminate or weaken the species barrier. Amino acid residues required for the interaction of prion proteins from two different species will also be identified to gain insight on the molecular interface important for heterotypic protein aggregation.

Progress 09/01/05 to 08/31/07

Outputs
OUTPUTS: The major output during the funding period has been research efforts to identify factors that influence prion propagation, prion transmission, and protein aggregation using yeast prions as a model system. Genetic screens were conducted to identify factors required for the faithful propagation and transmission of the yeast prion [PSI+]. Forty-two mutants with potential defects in prion propagation or transmission were identified. Characterization and cloning of several of the strongest mutants are well underway. It is anticipated the results of this study will be disseminated to the scientific community through publications in scholarly journals. PARTICIPANTS: Research was conducted by the principle investigator (L.A. Strawn) in the laboratory of Dr. Heather True-Krob at Washington University School of Medicine as part of her postdoctoral training. TARGET AUDIENCES: The target audience is the scientific community, which will gain information on factors influencing prion propagation and transmission. PROJECT MODIFICATIONS: The change in approach was outlined in the progress report for the first year of the funding period.

Impacts
Protein aggregation is the basis for several disorders, particularly neurodegenerative disorders, in both humans and animals. In the case of prion diseases, the disease-causing agent is transmissible between humans and animals through the food supply. Normally, a barrier to transmission of prions between species exists. However, in some instances there is evidence that the species barrier can be overcome. Studies on protein aggregation and factors that influence prion transmission and propagation in yeast may provide insight into the heterotypic aggregation that may occur during interspecies prion transmission. Factors identified using the yeast model system may provide the basis for future studies using animal model systems.

Publications

  • Strawn, L.A., and H.L. True. 2006. Deletion of RNQ1 Gene Reveals Novel Functional Relationship between Divergently Transcribed Bik1p/CLIP-170 and Sfi1p in Spindle Pole Body Separation. Curr. Genet. 50:347-366.


Progress 09/01/05 to 08/31/06

Outputs
The goal of this project is to use yeast prions as a model system to screen for factors that influence prion propagation, prion transmission, and heterotypic protein aggregation. We proposed to use a cytosolic protein-protein interaction system with the Sup35p prion-forming domains of two yeast species (both induced into the [PSI+] prion conformation) as our screenable system. We set up two different protein-protein interaction systems, but neither system worked correctly due to technical problems with the systems. Since we were unable to set up a suitable screening method to permit studying the interaction of prion proteins from two species within the same cell, we adopted another approach to understand more about heterotypic protein aggregation. Prion proteins from one species are not always capable of inducing conversion of the same protein from another species into a prion state (a species barrier to transmission exists). Conversely, within one species two different prions can sometimes influence conversion frequencies of each other. It is intriguing how a strong species barrier may be the result of minor changes in primary sequence, yet one prion protein can serve to induce a prion conformation in a completely unrelated protein. By studying the heterotypic aggregation of two different prions from one species we will gain information that can be applied to the heterotypic aggregation that may occur during interspecies prion transmission. The Saccharomyces cerevisiae [RNQ+] prion influences the formation of [PSI+] potentially by acting as a seed onto which Sup35p can aggregate to form [PSI+] (Derkatch et al. 2000 EMBO J 19:1942-52). However, this system is currently limited in utility because the function of Rnq1p is unknown. We set up genetic screens to identify factors that are related to the function of Rnq1p. While screening for genetic interactions with RNQ1, we serendipitously uncovered a novel interactor with the divergently transcribed BIK1 gene. This was uncovered because our deletion of RNQ1 lead to a great decrease in the expression of Bik1p. The characterization of this interaction is currently in press for publication, and we are completing a second screen for mutants directly related to RNQ1. We hope to use information gained about Rnq1p function to devise novel strategies to examine heterotypic aggregation between Rnq1p in [RNQ+] and Sup35p in [PSI+].

Impacts
Protein aggregation is the basis for several disorders, particularly neurodegenerative disorders, in both humans and animals. In the case of prion diseases, the disease-causing agent is transmissible between animals and humans through the food supply. Normally, a barrier to transmission of prions between species exists. However, in some instances there is evidence that the species barrier can be overcome. Studies on heterotypic protein aggregation and factors that influence protein aggregation may provide insight into the heterotypic aggregation that may occur during interspecies prion transmission.

Publications

  • Strawn, L.A., and H.L. True. 2006. Deletion of RNQ1 Gene Reveals Novel Functional Relationship between Divergently Transcribed Bik1p/CLIP-170 and Sfi1p in Spindle Pole Body Separation. Curr. Genet., In press.